Verona Pharma plc Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2020 to Q3 2024
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Verona Pharma plc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2020 to Q3 2024.
- Verona Pharma plc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 652M shares, a 2.15% increase year-over-year.
- Verona Pharma plc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 634M shares, a 19.9% increase from 2022.
- Verona Pharma plc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 529M shares, a 11.8% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)